FILANA THERAPEUTICS, INC.

FLNA

FILANA THERAPEUTICS, INC.

FLNA

Insider Sentiment (TTM):

Last Purchase:2025-11-24Last Sale:2024-11-29Shares Purchased (TTM):300,190Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:13,108,143Shares Outstanding:48,297,000Institutional Ownership Pct.:27.14%

Earnings Market Reaction:

Filing Date:2026-05-07Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets Current
Cash And Cash Equivalents At Carrying Value	87	96	106	112	117	129	149	207	124	121	142	168
Restricted Cash Current	-	-	-	-	-	-	40	-	-	-	0	-
Prepaid Expense And Other Assets Current	1	2	3	2	3	8	14	15	10	8	8	8
Assets Current	88	98	109	115	120	137	203	222	134	130	150	175
Property Plant And Equipment Net	20	21	21	21	21	21	21	21	22	22	22	22
Operating Lease Right Of Use Asset	-	-	-	-	-	-	-	-	-	0	0	-
Assets	108	118	130	135	141	158	224	244	156	152	173	197
Intangible Assets Net Excluding Goodwill	-	-	-	-	-	0	0	0	0	0	0	0
Liabilities Current
Accounts Payable And Other Accrued Liabilities Cur…	39	42	46	43	8	8	52	53	10	11	9	10
Accrued Liabilities Current	-	-	-	-	-	-	-	-	-	-	-	7
Employee Related Liabilities Current	0	2	0	1	1	1	2	0	0	0	0	0
Derivative Liabilities Current	-	-	-	-	-	-	-	-	65	-	-	-
Other Liabilities Current	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities Current	40	44	48	47	13	12	57	55	77	14	17	18
Operating Lease Liability Current	-	-	-	-	-	-	-	-	-	0	0	-
Other Liabilities Noncurrent	0	0	0	0	0	0	0	-	-	0	0	-
Liabilities	40	44	48	47	13	12	57	-	-	14	17	18
Operating Lease Liability Noncurrent	-	-	-	-	-	-	-	-	-	0	0	-
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	-
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	575	570	565	561	556	551	544	538	434	518	515	514
Retained Earnings Accumulated Deficit	-506	-496	-484	-473	-429	-405	-378	-350	-356	-381	-360	-334
Stockholders Equity	68	74	82	88	128	146	167	189	79	137	155	179
Liabilities And Stockholders Equity	108	118	130	135	141	158	224	244	156	152	173	197
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	120	120	120	120	120	120	120	120	120	120	120	120
Common Stock Shares Issued	48	48	48	48	48	48	48	48	43	42	42	42
Shares Outstanding	48	48	48	48	48	48	48	48	43	42	42	42

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	13.24%	-11.76%	-34.56%	-	-	-	-	-	-	-	-	-
2025	18.24%	2.94%	38.24%	-10.37%	50.62%	35.27%	-2.15%	-35.89%	-38.96%	-11.28%	-22.56%	-21.03%
2024	8.90%	-38.95%	-26.25%	10.34%	9.47%	2.04%	-84.85%	-90.13%	-90.06%	-33.47%	-36.69%	-14.92%
2023	-	-	-	-12.38%	-15.83%	-32.73%	-6.73%	0.94%	8.65%	-13.61%	-14.35%	0.83%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	2.19	2.23	2.27	2.43	9.08	11.62	3.55	4.07	1.74	9.13	8.62	9.75
Quick Ratio	2.16	2.18	2.21	2.37	8.86	10.94	3.31	3.80	1.61	8.53	8.17	9.28
Working Capital	47.85M	53.88M	60.86M	67.49M	106.91M	124.78M	145.52M	167.53M	56.88M	115.44M	132.77M	156.64M
Leverage & Debt
Debt to Equity	0.59	0.59	0.59	0.54	0.10	0.08	0.34	0.29	0.98	0.10	0.11	0.10
Interest Coverage TTM	-19.78	-20.65	-19.59	-18.19	-18.26	-16.62	-17.05	-18.05	-13.15	-13.53	-11.70	-12.65
Debt Ratio	0.37	0.37	0.37	0.35	0.09	0.08	0.26	0.22	0.50	0.09	0.10	0.09
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-	-1.88	-2.19	-2.55	-1.51	-0.52	-0.37	-0.33	-1.09	-2.32	-2.27	-2.15
Free Cash Flow Per Share TTM	-0.63	-0.68	-1.74	-1.99	-2.26	-2.53	-1.63	-1.87	-2.05	-1.97	-1.95	-1.86
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	7.02%	273.73%	500.27%	701.24%	51.95%	-74.96%	-81.49%	-82.93%	-42.28%	27.50%	33.88%	48.60%
EPS Growth (1Y)	6.92%	258.50%	496.14%	666.31%	35.38%	-77.34%	-83.80%	-84.56%	-43.97%	22.24%	27.65%	42.28%
Valuation Metrics
P/E TTM	-1.05	-1.05	-1.33	-0.71	-0.99	-4.49	-79.93	-37.12	-18.21	-9.71	-7.32	-11.38
P/B TTM	1.20	1.29	1.72	0.99	0.57	0.75	8.47	3.02	11.10	6.87	4.51	5.71
Market Cap	81.64M	95.63M	140.58M	87.44M	72.39M	109.34M	1.41B	570.59M	872.49M	943.89M	698.91M	1.02B
Enterprise Value	-4.93M	126.06K	34.50M	-24.94M	-44.94M	-19.24M	1.22B	363.30M	748.32M	822.75M	556.56M	856.33M
Calculated Values
Free Cash Flow TTM	-30.38M	-32.83M	-83.91M	-95.92M	-109.24M	-117.03M	-78.07M	-86.31M	-87.97M	-82.45M	-81.75M	-77.90M
Net Debt	-86.57M	-95.50M	-106.08M	-112.38M	-117.33M	-128.57M	-188.98M	-207.29M	-124.17M	-121.14M	-142.35M	-168.44M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-11-24Purchase

Owner: Anderson, Robert Eugene J…

Title: -

Shares: 8,600

Price/Share: $2.90

Value: $24,940.00

Shares Owned: 8,600

Relationship: Director

Ownership: Direct

2025-11-20Purchase

Owner: Barry, Richard

Title: President & CEO

Shares: 150,000

Price/Share: $2.76

Value: $414,000.00

Shares Owned: 938,060

Relationship: Director,Officer

Ownership: Indirect

2025-11-19Purchase

Owner: Barry, Richard

Title: President & CEO

Shares: 73,385

Price/Share: $2.75

Value: $201,808.75

Shares Owned: 788,060

Relationship: Director,Officer

Ownership: Indirect

2025-09-30Purchase

Owner: Cook, Robert Christopher

Title: Chief Operating & Legal Office

Shares: 13,725

Price/Share: $2.91

Value: $39,939.75

Shares Owned: 13,725

Relationship: Officer

Ownership: Direct

2025-09-22Purchase

Owner: Barry, Richard

Title: President & CEO

Shares: 7,172

Price/Share: $2.28

Value: $16,352.16

Shares Owned: 714,675

Relationship: Director,Officer

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-11-24	Anderson, Robert Eugene J…	Director	-	Direct	Purchase	8,600	2.90	$24,940.00	8,600	4
2025-11-20	Barry, Richard	Director,Officer	President & CEO	Indirect	Purchase	150,000	2.76	$414,000.00	938,060	4
2025-11-19	Barry, Richard	Director,Officer	President & CEO	Indirect	Purchase	73,385	2.75	$201,808.75	788,060	4
2025-09-30	Cook, Robert Christopher	Officer	Chief Operating & Legal Office	Direct	Purchase	13,725	2.91	$39,939.75	13,725	4
2025-09-22	Barry, Richard	Director,Officer	President & CEO	Indirect	Purchase	7,172	2.28	$16,352.16	714,675	4
2025-09-19	Barry, Richard	Director,Officer	President & CEO	Indirect	Purchase	47,308	2.27	$107,389.16	707,503	4
2024-11-29	Kupiec, James William	Officer	Chief Medical Officer	Direct	Sale	4,000	3.87	$15,480.00	0	4
2024-11-29	Schoen, Eric	Officer	Chief Financial Officer	Direct	Sale	59,800	3.86	$230,828.00	11,500	4
2023-08-23	Robertson, Sanford	Director	-	Direct	Purchase	30,000	17.45	$523,500.00	886,851	4
2023-08-22	Barry, Richard	Director	-	Indirect	Purchase	16,571	16.65	$275,907.15	293,477	4
2023-03-07	Barry, Richard	Director	-	Indirect	Purchase	77,276	25.76	$1,990,629.76	275,000	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

27.14%

Inst. Shares: 13,108,143

Shares Outstanding: 48,297,000

2025-12-31

27.13%

Inst. Shares: 13,101,728

Shares Outstanding: 48,297,000

2025-09-30

28.13%

Inst. Shares: 13,590,425

Shares Outstanding: 48,308,000

2025-06-30

25.08%

Inst. Shares: 12,114,844

Shares Outstanding: 48,308,000

2025-03-31

32.36%

Inst. Shares: 15,618,853

Shares Outstanding: 48,262,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	13,108,143	48,297,000	27.14%
2025-12-31	13,101,728	48,297,000	27.13%
2025-09-30	13,590,425	48,308,000	28.13%
2025-06-30	12,114,844	48,308,000	25.08%
2025-03-31	15,618,853	48,262,000	32.36%
2024-12-31	17,113,022	46,329,000	36.94%
2024-09-30	13,643,228	47,976,000	28.44%
2024-06-30	13,117,743	46,202,000	28.39%
2024-03-31	11,177,532	43,001,000	25.99%
2023-12-31	12,967,572	41,932,000	30.93%
2023-09-30	12,236,675	42,002,000	29.13%
2023-06-30	11,014,431	41,793,000	26.35%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

FILANA THERAPEUTICS, INC. (FLNA) — SEC Financial Statements & Analysis

FILANA THERAPEUTICS, INC. (FLNA) is a pharmaceutical preparations company, incorporated in DE. FILANA THERAPEUTICS, INC. trades on Nasdaq as: FLNA. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), FILANA THERAPEUTICS, INC. reported a Debt-to-Equity ratio of 0.59x, a Price-to-Book (P/B) ratio of 1.20x (TTM), at a market cap of $81.64M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.59x
P/B TTM: 1.20x
Market Cap: $81.64M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is FILANA THERAPEUTICS, INC. in?

FILANA THERAPEUTICS, INC. (FLNA) operates in the Pharmaceutical Preparations industry.

What is FLNA's market cap?

FILANA THERAPEUTICS, INC. (FLNA) has a market capitalization of $81.64M as of 2026-03-31.

What exchange does FLNA trade on?

FILANA THERAPEUTICS, INC. (FLNA) trades on the Nasdaq.

Where is FILANA THERAPEUTICS, INC. incorporated?

FILANA THERAPEUTICS, INC. is incorporated in DE.